Results 81 to 90 of about 452,379 (303)

Developmental programmes drive cellular plasticity, disease progression and therapy resistance in lung adenocarcinoma

open access: yesMolecular Oncology, EarlyView.
This study shows that lung adenocarcinomas exploit developmental branching morphogenesis to acquire a therapy resistant basal‐like tumour cell state. This process was found to be regulated by combined TP53 loss‐of‐function and type‐I interferon signalling, identifying a novel axis for biomarker and therapeutic target discovery.
Kamila J Bienkowska   +13 more
wiley   +1 more source

Extreme value theory applied to the auroral electrojet indices

open access: yesEarth and Planetary Physics
The study of extreme weather and space events has gained paramount importance in modern society owing to rapid advances in high technology. Understanding and describing exceptional occurrences plays a crucial role in making decisive assessments of their ...
Si Chen   +4 more
doaj   +1 more source

Threshold autoregression with a near unit root [PDF]

open access: yes
unit root;autoregressive ...
Hansen,B.E., Caner,M.
core  

Supplemental Material, Supplemental_1_References_for_145_TLVs_Alphabetical_Order - 142 ACGIH Threshold Limit Values® (TLV®s) established from 2008-2018 lack consistency and transparency

open access: yes, 2019
Supplemental Material, Supplemental_1_References_for_145_TLVs_Alphabetical_Order for 142 ACGIH Threshold Limit Values® (TLV®s) established from 2008-2018 lack consistency and transparency by Carr J Smith, and Thomas A Perfetti in Toxicology Research and ...
Thomas A Perfetti (5195048)   +1 more
core   +1 more source

Finding novel vulnerabilities of hypomorphic BRCA1 alleles

open access: yesMolecular Oncology, EarlyView.
Synthetic lethality screens performed to identify novel vulnerabilities often model complete gene loss, thereby overlooking patient‐derived hypomorphic mutations. In this study, we have performed genome‐wide CRISPR screens on BRCA1 hypomorphic mutations, showing BRCA1I26A behaves like wild‐type, while BRCA1R1699Q mimics deficiency. Furthermore, we have
Anne Schreuder   +10 more
wiley   +1 more source

Carrier-to-Noise-Threshold Filtering on Off-Shore Wind Lidar Measurements

open access: yesSensors, 2019
Wind lidar observations are characterized by a Carrier-to-Noise-Ratio that is often used to filter the observations. The choice of the Carrier-to-Noise-Ratio threshold value for the wind lidar observations is found to have an effect on the climatological
Sven-Erik Gryning, Rogier Floors
doaj   +1 more source

Longitudinal genome‐wide aneuploidy measurements in circulating cell‐free DNA to predict lack of benefit from pembrolizumab in patients with metastatic urothelial cancer

open access: yesMolecular Oncology, EarlyView.
Many patients with urothelial cancer do not benefit from treatment with pembrolizumab, while at risk of severe side effects. Changes in the levels of circulating tumor DNA early during treatment, measured by a simple and affordable assay that can be easily implemented in the clinic, can be used as a prognostic tool to identify these patients.
Youssra Salhi   +14 more
wiley   +1 more source

Graphical identification of TAR models [PDF]

open access: yes
This paper proposes an automatic procedure to identify Threshold Autoregressive models and specify the threshold values. The proposed procedure is based on recursive estimation of arranged autoregression. The main advantage of the proposed procedure over
Daniel Peña   +2 more
core  

A novel quinazolinone insulin receptor inhibitor and its synergy with an EGFR inhibitor in glucose‐driven glioblastoma

open access: yesMolecular Oncology, EarlyView.
The novel styrylquinazolinone‐based molecule W1B effectively suppresses glioblastoma by inhibiting IGF1R and EGFR. In high‐glucose microenvironments driving tumor resistance, W1B acts synergistically with the EGFR inhibitor dacomitinib. This combination safely blocks compensatory survival signaling in zebrafish xenograft models. Showcasing promising in
Patryk Rurka   +9 more
wiley   +1 more source

Oncogenic DMTF1β promotes cancer cell motility by regulating autophagy through ULK1 stabilization

open access: yesMolecular Oncology, EarlyView.
In the current study, we demonstrate that the oncogene DMTF1β regulates ULK1 stability by reducing its proteasomal degradation in cancer cells. This stabilization enables ULK1 to induce autophagy, which in turn facilitates cancer cell migration. Consequently, reduced DMTF1β levels lead to decreased autophagy and impaired cancer cell migration.
Jun Xu   +13 more
wiley   +1 more source

Home - About - Disclaimer - Privacy